
FDA Unveils Landmark Roadmap to Replace Animal Testing in Preclinical Safety Studies
Key Points: FDA aims to make animal studies the exception rather than the norm within 3–5 years by embracing new approach methodologies (NAMs) based on
Sign up to our newsletter for all the latest news and SMS campaign alerts.
"*" indicates required fields